文献速递质量管理与危急值临床生化

一种确定试剂批间允许变异的方法

An approach for determining allowable between reagent lot variation.
PubMed 文献 · Clin Chem Lab Med · 2022-02-16

本文提出一个模型,用于将允许的室内精密度测量不确定度(uRw)的一部分分配给试剂批间变异,基于特定被测量长期一致性的需求。该分配管理短期与长期变异之比,并指示实验室何时应拒绝或纠正试剂批间变异。

要点

  • 试剂批间变异可影响uRw,需纳入分析性能规范管理。
  • 模型将部分允许uRw分配给批间变异以保障长期一致性。
  • 模型指示实验室何时应拒绝或纠正试剂批间变异。

核心结论

  • 提出一个基于长期一致性需求将允许uRw部分分配给试剂批间变异的模型。

主要发现

  • 试剂和/或校准品批间漂移引起的显著偏倚若被接受或未被注意会成为分析性能特征的因素。
  • 模型管理短期与长期变异之比并指示实验室何时拒绝或纠正试剂批间变异。

临床怎么用

  • 实验室可利用该模型判断试剂批间变异是否需拒绝或纠正以维持测量程序 adequacy。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Clinicians trust medical laboratories to provide reliable results on which they rely for clinical decisions. Laboratories fulfil their responsibility for accurate and consistent results by utilizing an arsenal of approaches, ranging from validation and verification experiments to daily quality control procedures. All these procedures verify, on different moments, that the results of a certain examination procedure have analytical performance characteristics (APC) that meet analytical performance specifications (APS) set for a particular intended use. The APC can in part be determined by estimating the measurement uncertainty component under conditions of within-laboratory precision (uRw), which comprises all components influencing the measurement uncertainty of random sources. To maintain the adequacy of their measurement procedures, laboratories need to distinguish aspects that are manageable vs. those that are not. One of the aspects that may influence uRw is the momentary significant bias caused by shifts in reagent and/or calibrator lots, which, when accepted or unnoticed, become a factor of the APC. In this paper, we postulate a model for allocating a part of allowable uRw to between-reagent lot variation, based on the need for long-term consistency of the measurement variability for that specific measurand. The allocation manages the ratio between short-term and long-term variation and indicates laboratories when to reject or correct certain variations due to reagent lots.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. van Schrojenstein Lantman M, Çubukçu HC, Boursier G, et al. An approach for determining allowable between reagent lot variation. Clin Chem Lab Med. 2022. PMID: 35172415. doi:10.1515/cclm-2022-0083

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。